Your browser doesn't support javascript.
loading
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study.
Weintraub, Daniel; Picillo, Marina; Cho, Hyunkeun Ryan; Caspell-Garcia, Chelsea; Blauwendraat, Cornelis; Brown, Ethan G; Chahine, Lana M; Coffey, Christopher S; Dobkin, Roseanne D; Foroud, Tatiana; Galasko, Doug; Kieburtz, Karl; Marek, Kenneth; Merchant, Kalpana; Mollenhauer, Brit; Poston, Kathleen L; Simuni, Tanya; Siderowf, Andrew; Singleton, Andrew; Seibyl, John; Tanner, Caroline M.
Afiliação
  • Weintraub D; Department of Psychiatry Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania USA.
  • Picillo M; Assistant Professor in Neurology at the Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana" University of Salerno Italy.
  • Cho HR; Department of Biostatistics, College of Public Health University of Iowa Iowa City Iowa USA.
  • Caspell-Garcia C; Department of Biostatistics, College of Public Health University of Iowa Iowa City Iowa USA.
  • Blauwendraat C; Center for Alzheimer's and Related Dementias, and the Integrative Neurogenomics Unit, Laboratory of Neurogenetics National Institute on Aging, National Institutes of Health Bethesda Maryland USA.
  • Brown EG; Department of Neurology Weill Institute for Neurosciences, University of California, San Francisco San Francisco California USA.
  • Chahine LM; Department of Neurology University of Pittsburgh Pittsburgh Pennsylvania USA.
  • Coffey CS; Department of Biostatistics, College of Public Health University of Iowa Iowa City Iowa USA.
  • Dobkin RD; Department of Psychiatry Rutgers University, Robert Wood Johnson Medical School Piscataway New Jersey USA.
  • Foroud T; Department of Medical and Molecular Genetics Indiana University Indianapolis Indiana USA.
  • Galasko D; Department of Neurology University of California San Diego California USA.
  • Kieburtz K; Department of Neurology University of Rochester Medical Center Rochester New York USA.
  • Marek K; Institute for Neurodegenerative Disorders New Haven Connecticut USA.
  • Merchant K; Department of Neurology Northwestern University Feinberg School of Medicine Chicago Illinois USA.
  • Mollenhauer B; Department of Neurology University Medical Center Goettingen Goettingen Germany.
  • Poston KL; Department of Neurology and Neurological Sciences Stanford University Stanford California USA.
  • Simuni T; Department of Neurology Northwestern University Feinberg School of Medicine Chicago Illinois USA.
  • Siderowf A; Department of Neurology Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA.
  • Singleton A; Center for Alzheimer's and Related Dementias, and the Molecular Genetics Section Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health Bethesda Maryland USA.
  • Seibyl J; Institute for Neurodegenerative Disorders New Haven Connecticut USA.
  • Tanner CM; Department of Neurology Weill Institute for Neurosciences, University of California, San Francisco San Francisco California USA.
Mov Disord Clin Pract ; 10(6): 943-955, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37332638
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article